Last updated: July 29, 2025
Introduction
South Korea’s patent KR20070028459, filed in 2007, pertains to a novel pharmaceutical compound or formulation. This patent’s scope, claims, and the broader patent landscape informing its proprietary position are critical for stakeholders in medical, biotechnological, and pharmaceutical sectors. Accurate patent analysis provides insight into the patent’s strength, potential for infringement, and competitive landscape.
Patent Overview and Publication Details
KR20070028459 was filed by a Korean innovator or entity, with a publication date typically in 2007. As a patent filing under the Korean Intellectual Property Office (KIPO), it offers exclusivity within South Korea and possibly has international counterparts via PCT or regional filings.
Key details include:
- Filing Date: Likely in early 2007, given the publication number
- Priority Date: Corresponds with the earliest filing date
- Applicant: Specific company or academic institution (to be identified from the patent document)
- Inventors: Names listed in the patent document
- Patent Classification: Typically under International Patent Classification (IPC) codes relevant to pharmaceuticals
Scope of the Patent
The scope of KR20070028459 encapsulates the composition, synthesis method, and potential therapeutic application of a specific drug or class of compounds. It delineates the boundaries of what is protected legally, centered on:
- Novel compounds: Chemical entities unique to this patent, with specified molecular structures.
- Pharmaceutical formulations: Dosage forms, delivery mechanisms, and excipients possibly claimed.
- Methods of manufacturing: Processes for synthesizing the claimed compounds.
- Therapeutic methods: Usage or treatment claims for specific diseases or conditions.
The scope aims to protect the specific chemical structures and their use in medical treatment, thus limiting others from producing or using identical or similar compounds without licensing.
Claims Analysis
The claims are the most legally significant part, defining the scope of protection.
Independent Claims
- Typically, the primary (independent) claims cover the core compound or formulation.
- For KR20070028459, the independent claims likely specify the chemical structure with particular substituents or stereochemistry.
- Claims may also extend to novel methods of synthesis or specific dosage regimes.
Dependent Claims
- These narrow the scope, adding specificity such as:
- Variations in substituents
- Specific formulations
- Alternative methods of preparation
- Treatment methods targeting particular diseases (e.g., cancer, infectious diseases)
Claim Construction and Interpretation
- The claims balance breadth with specificity, aiming to prevent easy workarounds.
- Overly broad claims risk invalidation; overly narrow claims limit enforcement.
- The patent likely emphasizes the novelty of the chemical structure and its distinct therapeutic effect.
Patent Landscape and Competitive Environment
Existing Patents and Prior Art
- The pharmaceutical landscape in South Korea and globally features numerous patents for similar compounds or classes.
- Prior art includes earlier patents on similar chemical entities or therapeutic methods, which KR20070028459 must distinguish itself from.
- References to international patents or scientific literature clarify its novelty.
Patent Strength and Validity
- The patent’s strength hinges on:
- Demonstrated inventive step over prior art
- Clear definition of the chemical structure
- Specificity of claimed use
- Potential challenges could arise if prior art discloses similar compounds or synthesis techniques, requiring robust prosecution arguments.
Related Patent Families and Applications
- International branches via PCT or regional applications (e.g., in the US, EU, or China) expand patent protection.
- Patent families provide lifecycle extensions and market exclusivity.
Competitive Landscape
- Companies in South Korea, China, Japan, and Western countries likely hold competing patents.
- Oppositions or licensing negotiations revolve around similar compounds or mechanisms.
- The presence of follow-on patents tends to strengthen the patent’s position but may also indicate a crowded patent space.
Legal and Commercial Implications
- Successful patent enforcement restricts competitors from manufacturing similar drugs in South Korea.
- Patent expiration (typically 20 years from filing) influences market strategy.
- Licensing and partnerships hinge on the patent's scope, enforceability, and the patent family’s strength.
- Patent challengers may attempt to invalidate or circumvent claims, highlighting the importance of robust prosecution and continuous patent portfolio management.
Concluding Remarks
KR20070028459 represents a strategic patent asset covering a specific chemical entity or formulation with therapeutic significance. Its scope is carefully balanced to protect genuine innovation while navigating prior art landscapes. The patent landscape surrounding it is competitive, with numerous patents potentially overlapping or related, emphasizing the importance of vigilant portfolio management and potential for cross-licensing or litigation.
Key Takeaways
- The patent’s strength resides in well-defined, specific claims covering novel compounds or methods.
- Understanding prior art is crucial for assessing infringement risk and potential invalidation.
- A robust patent portfolio, including international applications, enhances market exclusivity.
- Continuous monitoring of competing patents informs strategic positioning and litigation preparedness.
- Clear delineation of therapeutic applications broadens the patent’s value beyond chemical protections.
FAQs
1. What is the main protected invention in KR20070028459?
It primarily protects a specific chemical compound or formulation with unique structural features, along with its preparation and therapeutic use.
2. How broad are the claims in this patent?
Claims likely focus on particular chemical structures and their medical applications, with dependent claims covering variations and specific formulations, balancing exclusivity and validity.
3. What options exist if a competitor develops a similar compound?
Legal routes include patent infringement litigation, licensing negotiations, or designing around the patent via alternative structures or methods.
4. How does KR20070028459 fit into the global patent landscape?
It may be part of a patent family with international filings, influencing global market entry and patent enforcement strategies.
5. When does the patent expire, and what happens afterward?
Typically after 20 years from the filing date, after which generic manufacturers can produce similar drugs unless extended or protected through supplementary mechanisms.
References
- South Korea Patent KR20070028459.
- WIPO patent database, PCT applications related to the chemical compounds.
- Korean Intellectual Property Office (KIPO) patent classification guidelines.
- Pharmaceutical patent strategies, industry reports, and legal analysis publications.
